Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effects of high-dose, intravenous lipid emulsion on laboratory tests in humans: a randomized, placebo-controlled, double-blind, clinical crossover trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Development and validation of a mass spectrometry-based assay for quantification of insulin-like factor 3 in human serum

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Gender-partitioned patient medians of serum albumin requested by general practitioners for the assessment of analytical stability

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Individual values of antineutrophil cytoplasmic antibodies do not correspond between antigen-specific assays

    Research output: Contribution to journalLetterResearchpeer-review

  4. Precision of nonfasting lipid profiles should focus on clinical relevance rather than necessarily obtaining the least variation

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Analgesics use and withdrawal in people with dementia - a register-based Danish study and a systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Fracture-induced changes in biomarkers CTX, PINP, OC, and BAP - a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  3. Multiple Fractures and Impaired Bone Fracture Healing in a Patient with Pycnodysostosis and Hypophosphatasia

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background Intravenous lipid emulsion (ILE) is used to treat drug poisonings. The resultant hyperlipemia may affect laboratory tests but the consequences are poorly characterized. In a clinical trial we therefore investigated the effects of ILE on laboratory tests analyzed on common analytical platforms (Roche® cobas 8000 and SYSMEX® flow-cytometry). Methods Ten healthy participants each completed 4 trial days (two with ILE and two with placebo). ILE (5.25 mL/kg) was administered from 12.5 to 30 min from baseline. At 0, 30 and 60 min, blood samples were drawn for measurement of 20 analytes. We investigated the effects of ILE on analyte levels and frequencies of exceedance of predefined analyzer hemolysis (H) or lipemia (L)-index cut-offs and test-specific reference change values (RCVs) on ILE-days. If the results were blocked due to exceedance of index values, we manually extracted the results. Results Sixteen out of 20 tests were blocked because H- or L-index cut-offs were exceeded on ILE-days. Differences in analyte levels between ILE- and placebo-days above the RCV were observed for aspartate aminotransferase, total calcium, lactate dehydrogenase (LDH), sodium and neutrophils. Mean values outside the normal range after ILE were observed for LDH (219 U/L), sodium (135.3 mmol/L) and total calcium (2.1 mmol/L). Conclusions ILE-infusion caused report failure of nearly all laboratory tests performed on a cobas 8000-platform, but it was possible to manually retrieve the results. For most test results - particularly alkaline phosphatase, bilirubin, phosphate and carbamide - the consequences of ILE were marginal, and the effects of ILE were reduced at the 60-min timepoint.

Original languageEnglish
JournalClinical Chemistry and Laboratory Medicine
Volume56
Issue number12
Pages (from-to)2047-2057
Number of pages11
ISSN1434-6621
DOIs
Publication statusPublished - 27 Nov 2018

ID: 55740861